Shijiazhuang, China

Linjing Fan

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2019-2020.


% Patents Active = 100.0


 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Linjing Fan: Innovator in Pharmaceutical Chemistry

Introduction

Linjing Fan is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of quinazoline derivatives. With a total of 2 patents, his work has the potential to impact cancer treatment.

Latest Patents

Linjing Fan's latest patents focus on quinazoline derivatives. These patents provide a quinazoline derivative, a pharmaceutical composition containing the same, a method for the preparation of said derivative, and an application of the same as an anti-cancer drug. This innovative approach highlights his commitment to advancing medical science.

Career Highlights

Throughout his career, Linjing Fan has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. and Cspc Zhongqi Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in drug development.

Collaborations

Linjing Fan has collaborated with several professionals in his field, including Ying Shi and Qingzhi Gao. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Linjing Fan is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new cancer treatments. His patents and collaborations reflect his dedication to improving healthcare through innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…